George Tziras
Vermögen: 165 029 $ am 31.05.2026
Vermögen: 165 029 $ am 31.05.2026
George Tziras currently works at Small Pharma, Inc., as Chief Executive Officer & Director from 2022, Cybin UK Ltd., as Non-Executive Director from 2015, and Cybin, Inc., as Chief Business Officer from 2025.
Mr. Tziras also formerly worked at Unilock Capital Corp., as Chief Business Officer & Director.
Mr. Tziras received his undergraduate degree from the University of Oxford and graduate degree from The Paul H.
Nitze School of Advanced International Studies.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYBIN, INC. 0,07 % | 20.02.2026 | 36 270 ( 0,07 % ) | 165 029 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SMALL PHARMA INC. | Vorstandsvorsitzender | 20.07.2022 |
| CYBIN INC. | Corporate Officer/Principal | 23.10.2023 |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Direktor/Vorstandsmitglied | 01.01.2015 |
| Unternehmen | Position | Ende |
|---|---|---|
| SMALL PHARMA INC. | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen